The use of the medications Wegovy, Ozempic, and Zepbound has skyrocketed as people turn to GLP-1 medications to treat diabetes and obesity
Kampo Med
Glp-1 (Glucagon Like Peptide) Single molecule made in the small intestine and colon Causes the pancreas to make insulin when sugar is in the blood stream, in a dose dependent fashion (the more sugar you have, the more GLP-1 tells the pancreas to release insulin) Tells the gastrointestinal tract to slow down digestion Slows down carbohydrate absorption (so your blood sugar doesnt escalate quickly) Curbs appetite Animal studies show GLP-1 may promote regeneration of the beta cells in the pancreas by fighting programmed cell death (apoptosis)
Frequency: one subcutaneous injection each day for 812 weeks (optionally extended to 16)
This may eventually lead to [4]: Heart disease Vision loss Kidney disease Fortunately, GLP-1 drugs are an effective medication used to treat type 2 diabetes
3.1.2 Bacteroidetes related toAD Recent scholarly investigations indicated that dysbiosis of the gut microbiota may facilitate the aggregation of amyloid-, neuroinflammatory responses, oxidative stress, and insulin resistance, which are implicated in the pathogenesis of AD (Vogt et al., 2017)